Criteria for use of omics-based predictors in NCI-sponsored clinical trials.

58 Background: High-throughput omics technologies (e.g., genomics, epigenomics, proteomics, metabolomics) offer exciting opportunities for new biological insights into cancer. The IOM report on tra...